SEC filings mandate institutional investment disclosure regarding AstraZeneca, Amundi's increased holdings, and Morgan Stanley's advice.
2 reports, 1 independent
Updated Aug 30
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
SEC filings mandate institutional investment disclosure regarding AstraZeneca, Amundi's increased holdings, and Morgan Stanley's advice.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
AstraZeneca
British-Swedish pharmaceutical company
-
Amundi
French subsidiary jointly created by Crédit Agricole and Société Générale
-
Morgan Stanley
U.S. investment bank
Related events
- AutoZone's board authorized a stock buyback program amid increased stakes by Norges Bank and Morgan Stanley, requiring SEC filings.
- Cisco filed disclosures with the SEC, and Amundi adjusted its holdings in Cisco stock.
- Filing disclosures regarding institutional investment activity involving Fifth Third Bancorp, Morgan Stanley, and the Securities and Exchange Commission.
- Institutional investment adds to corporate profile involving Amundi, Hancock Whitney, and Keefe, Bruyette & Woods, leading to required SEC filings.
- Nebius Group filed required institutional holdings disclosures with the SEC after Amundi increased its stake in the company.